STAT published an account describing a meeting in which Beth Høeg presented evidence of young people who had died after Covid vaccination. According to STAT, her findings triggered pushback from career FDA regulators who feared the implications of acknowledging fatal cases.
A Reckoning Is Underway at the FDA Continue Reading
Will the ABC course-correct with Williams at the helm? Now that trust in legacy media is at historical lows, the ABC’s partnership with TNI does little to assuage fears that the network has passed the point of no return.
New ABC Fact-Checkers, Same Problems? Continue Reading
Prasad’s new framework has halted low-risk approvals unless backed by RCTs. Yes, the mRNA platform is still alive—and still fiercely protected—but reform was never going to be easy. And it was never going to come all at once.
Covid-19 Vaccine Reform Is Moving Slower Than Many Had Hoped Continue Reading
In January 2021, in the absence of any human data in pregnancy, the CDC stated on its website that mRNA vaccines were “unlikely to pose a specific risk for people who are pregnant.” Behind the scenes however, Pfizer was scrambling to conduct a clinical trial of its vaccine in pregnant women. By February 2022, Pfizer revealed it still did “not yet have a complete data set.”
Pfizer Drip Feeds Data From its Pregnancy Trial Continue Reading
I understand the need to protect national security, but safeguarding it must never become an excuse to silence legitimate scrutiny — or intimidate journalists whose role is to hold the powerful to account — or to punish whistleblowers exposing real wrongdoing.
Trump’s War on Leaks: Is Journalism the Next Casualty? Continue Reading
Major international governments have signed multibillion-dollar legal contracts with drug companies in order to secure access to covid-19 vaccines. But the drug companies and governments have refused to divulge details, saying the information is “commercial in confidence.”
Why the Secrecy Over Vaccine Contracts? Continue Reading
Unshrunk: A Story of Psychiatric Treatment Resistance is more than a memoir of Laura Delano’s journey through pain, survival, and recovery. It is a fearless, forensic examination of a psychiatric system that often harms those it is meant to help.
Unshrunk: Laura Delano’s Breakaway from Psychiatry Continue Reading
Levi is no stranger to weighing risk. A professor at MIT with deep experience in data analytics and risk-based decision-making, he had combed through five clinical trials of RSV monoclonals, including clesrovimab and its predecessor, nirsevimab.
Retsef Levi Explains His Vote against Routine RSV Monoclonal Use in Newborns Continue Reading
When an unpublished study from one of America’s most respected hospital networks surfaced in the US Senate last month, it reignited a fierce debate in medicine: are vaccinated children healthier than unvaccinated children?
Inside the Henry Ford Vaccine Controversy Continue Reading
Of all the antiviral drugs for Covid-19, Pfizer’s Paxlovid has been the most successful. Not for its safety and efficacy, but for its ability to earn the company billions in profits despite being largely ineffective for most people.
Is Paxlovid a Dud? Continue Reading
